HEALTHCARE SERVICES GROUP INC
HCSG$897M
Small CapNASDAQServices-Nursing & Personal Care Facilities🇺🇸North AmericaBENSALEM35.3K employees
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Jul 22, 2026
4wMarket Overview
Stock performance and key metrics
HCSG News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
123I-mIBG (meta-iodobenzylguanidine)
Heart Failure, Congestive
[18F] Flutemetamol
Healthy
HP-211
Type 2 Diabetes
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
123I-mIBG (meta-iodobenzylguanidine) | Phase 3 | Heart Failure, Congestive | - | - |
[18F] Flutemetamol | Phase 3 | Healthy | - | - |
HP-211 | Phase 2 | Type 2 Diabetes | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply